UNITED STATES SECURITIES AND EXCHANGE COMMISSION


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): November 30, 2004

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

Delaware

  (State or other jurisdiction of

incorporation or organization)

1-07151

31-0595760

(Commission File Number)

(I.R.S. Employer Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices)    (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

[ ]  Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 

ITEM 8.01  OTHER EVENTS

The information set forth in the Registrant’s press release regarding its proposed private placement of $1.65 billion aggregate principal amount of senior notes (the “Notes”), dated November 30, 2004, which is filed as exhibit 99.1 hereto, is incorporated herein by reference.

The information contained in this Current Report on Form 8-K is neither an offer to sell nor a solicitation of an offer to buy any of the Notes. The Notes to be offered will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

ITEM 9.01  FINANCIAL  STATEMENTS AND EXHIBITS SIGNATURES

(c)        Exhibits

Exhibit              Description

99.1                 Press Release, dated November 30, 2004.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

                                                                        THE CLOROX COMPANY

Date:  November 30, 2004                               By: /s/ PAMELA FLETCHER

                                                                                    Pamela Fletcher

                                                                                    Vice President - Secretary

                                                                                   



EXHIBIT INDEX

Exhibit              Description

99.1                 Press Release, dated November 30, 2004.